IRIS
TASCINI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.899
AS - Asia 6.730
EU - Europa 3.171
SA - Sud America 1.716
AF - Africa 170
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.707
SG - Singapore 3.647
BR - Brasile 1.423
IT - Italia 1.245
CN - Cina 914
HK - Hong Kong 902
VN - Vietnam 608
RU - Federazione Russa 459
IE - Irlanda 298
DE - Germania 257
IN - India 165
GB - Regno Unito 155
UA - Ucraina 131
AR - Argentina 107
SE - Svezia 105
FI - Finlandia 87
FR - Francia 85
CA - Canada 83
KR - Corea 80
AT - Austria 76
MX - Messico 69
BD - Bangladesh 64
TR - Turchia 60
ZA - Sudafrica 60
NL - Olanda 58
ID - Indonesia 57
EC - Ecuador 53
ES - Italia 43
PL - Polonia 42
CO - Colombia 39
JP - Giappone 38
IQ - Iraq 35
MA - Marocco 25
BE - Belgio 23
PK - Pakistan 23
VE - Venezuela 22
PE - Perù 19
PY - Paraguay 19
TG - Togo 19
UZ - Uzbekistan 17
CL - Cile 15
LT - Lituania 13
CH - Svizzera 12
TN - Tunisia 12
KE - Kenya 11
NP - Nepal 10
IL - Israele 9
TW - Taiwan 9
UY - Uruguay 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
EG - Egitto 8
JO - Giordania 8
LB - Libano 8
LV - Lettonia 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
PA - Panama 7
HU - Ungheria 6
KG - Kirghizistan 6
RS - Serbia 6
SA - Arabia Saudita 6
AO - Angola 5
AZ - Azerbaigian 5
CR - Costa Rica 5
GR - Grecia 5
PH - Filippine 5
RO - Romania 5
AU - Australia 4
DK - Danimarca 4
JM - Giamaica 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
BY - Bielorussia 3
BZ - Belize 3
EU - Europa 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
YE - Yemen 3
BS - Bahamas 2
CV - Capo Verde 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
Totale 18.654
Salva come PNG Salva come JPEG
Città #
Singapore 1.178
Hong Kong 886
Ashburn 736
Chandler 464
Beijing 444
Redmond 384
Boardman 363
Fairfield 307
Woodbridge 281
Dublin 280
Wilmington 252
Princeton 245
Dallas 234
Houston 218
Ho Chi Minh City 216
Los Angeles 193
Ann Arbor 180
Udine 174
Redondo Beach 148
Seattle 142
Cambridge 129
Buffalo 119
São Paulo 118
Hanoi 96
Milan 91
Mumbai 85
Hefei 83
Seoul 78
Dong Ket 76
New York 70
Munich 66
Rome 60
Belluno 54
Nuremberg 53
Dearborn 52
Jacksonville 52
Norwalk 44
Lappeenranta 41
Rio de Janeiro 39
Vienna 39
Izmir 38
Johannesburg 36
Tokyo 36
Frankfurt am Main 34
Ogden 34
Santa Clara 34
Trieste 33
Belo Horizonte 32
Chicago 32
San Diego 32
Warsaw 32
Montreal 31
Brasília 29
Mexico City 27
Guangzhou 26
London 26
Naples 26
Amsterdam 25
Denver 24
Haiphong 23
Phoenix 23
Turku 23
Brooklyn 22
Brussels 21
Des Moines 21
Düsseldorf 21
Orem 21
Atlanta 20
Bologna 20
Curitiba 20
Poplar 20
Lomé 19
Porto Alegre 18
Stockholm 18
Buenos Aires 17
Florence 17
The Dalles 17
Washington 17
Biên Hòa 16
Boston 16
Chennai 16
Da Nang 16
Hyderabad 16
Quito 16
Toronto 16
Venice 16
Campinas 15
Dhaka 15
Manchester 15
Santo André 15
Guarulhos 14
Salvador 14
San Francisco 14
Shanghai 14
Tashkent 14
Thái Bình 14
Bari 13
Guayaquil 13
Lima 13
Parma 13
Totale 10.059
Salva come PNG Salva come JPEG
Nome #
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 250
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 232
Gestione Diagnostico-Terapeutica del Paziente di Area Critica con Infezione Grave da Patogeni Batterici Multiresistenti 185
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 183
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 171
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 163
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 160
An Italian consensus for invasive candidiasis management (ITALIC) 159
MR-proADM as prognostic factor of outcome in COVID-19 patients 159
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 155
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 154
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 142
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 138
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 137
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 135
Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin” 134
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 131
Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study 131
Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement 123
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 120
The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data 119
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 116
Ceftobiprole: drug evaluation and place in therapy 115
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 111
The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery 108
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19 106
Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization 105
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination 105
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 104
KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study 102
INFEZIONI da GRAM POSITIVI per QUADRO SINDROMICO Dal laboratorio alla clinica 102
Acid-suppressant therapy does not influence absorption of azoles used in candidemia 101
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 100
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 100
Screening procedure for SARS-CoV-2 infection combining triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation recipients undergoing outpatient posttransplant follow-up 99
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly). 98
Use of colistin in adult patients: A cross-sectional study 97
Reading and understanding an antibiogram 96
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 96
Risk factors and outcome of c. Difficile infection after hematopoietic stem cell transplantation 91
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 91
Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles? 90
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature 88
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 87
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study 87
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 86
Enterobacterales multiresistenti - Dal laboratorio alla clinica 86
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 86
Extracellular vesicle features are associated with COVID-19 severity 84
A Novel Immunosuppressive Strategy Combined with Preemptive Antiviral Therapy Improves the Eighteen-Month Mortality in HCV Recipients Transplanted with Aged Livers 84
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 83
L'uso dei farmaci antimicrobici in terapia intensiva - Letteratura ragionata dell'antibiogramma 83
A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot 83
Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave 83
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 82
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 82
A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection 81
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 81
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection 80
L'uso dei Farmaci Antifungini nel Paziente Critico. Le Infezioni Fungine nel Paziente Critico dal Laboratorio alla Clinica per Ottimizzare la Diagnosi e la Terapia 79
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 78
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 77
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS 77
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway 77
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery 77
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis 77
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature 76
Accuracy of point-of-care ultrasound to identify the source of infection in septic patients: a prospective study-comment 75
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 74
L’interpretazione del fenotipo antibiotico come strumento per il clinico. 74
Pragmatic overview on acute bacterial and fungal infections of the central nervous system: a holistic update from diagnosis to treatment 73
A Rapid High-Performance Liquid Chromatography Method to Measure Linezolid and Daptomycin Concentrations in Human Plasma 73
A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study 73
A dangerous job 73
Eravacycline: Data Based on Real Evidence 72
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 72
A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION 72
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 71
Cefditoren: a clinical overview 71
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 71
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 69
The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review—To Do Small Things in a Great Way 69
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 69
Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19 69
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience 69
Monitoring the SPREAD of the SARS-CoV-2 lineage B.1.621 in Udine, Italy 69
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 68
A neglected outbreak in a long-term care facility: Scabies 68
Liposome composition of colistin for intravenous, oral, and cutaneous therapheutic use, and process for its preparation 68
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 67
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 67
Approach to patients with COVID-19 disease: The procedure in Udine 67
Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6” 67
Barotrauma during Noninvasive Respiratory Support in COVID-19 Pneumonia Outside ICU: The Ancillary COVIMIX-2 Study 66
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 66
A proposal for distinguishing between bacterial and viral meningitis using genetic programming and decision trees 66
Prévalence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques traités par biothérapies ou inhibiteurs des JAK : une étude basée sur la population au cours des deux premiers mois de l’épidémie de COVID-19 en Italie 66
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 65
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection 64
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 64
Totale 9.745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.840 0 0 0 0 0 72 60 411 959 99 124 115
2021/20221.478 78 78 74 50 85 31 52 105 95 222 331 277
2022/20231.506 271 124 21 141 121 410 47 70 168 15 65 53
2023/2024922 102 46 60 52 98 108 41 147 59 83 37 89
2024/20255.961 143 364 215 250 136 263 403 309 837 519 966 1.556
2025/20266.829 831 1.277 1.238 1.433 1.728 322 0 0 0 0 0 0
Totale 20.029